Quantitative comparison of CDKN2B methylation in pediatric and adult myelodysplastic syndromes

Acta Haematologica

Volumn 130, Issue 2, 2013, Pages 115-121

  Kim, Miyoung ^a   Kook, Hoon ^b   Park, Hyeon Jin ^c   Ahn, Hyo Seop ⁱ   Lee, Kwang Chul ^h   Lee, Kun Soo ^d   Park, Sang Kyu ^e   Lim, Jae Young ^f   Kim, Hyun Kyung ^g   Han, Dong Kyun ^b   Lee, Dong Soon ^g,i  

^a Hallym University   (South Korea)

^b Chonnam National University Research Institute of Medical Sciences   (South Korea)

^c National Cancer Center   (South Korea)

^d Kyungpook National University Hospital   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Gyeongsang National University   (South Korea)

^g Seoul National University Hospital   (South Korea)

^h College of Medicine   (South Korea)

ⁱ Seoul National University   (South Korea)

Author keywords

CDKN2B; Methylation; Myelodysplasia; Pyrosequencing

Indexed keywords

GENOMIC DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2B;

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER PROGNOSIS; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; METHYLATION; MYELODYSPLASTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; SCHOOL CHILD; BLAST CELL; CANCER SURVIVAL; CDKN2B GENE; CHROMOSOME ABERRATION; DNA METHYLATION; GENETIC ASSOCIATION; GROUPS BY AGE; OVERALL SURVIVAL; PATHOGENESIS; PROGNOSIS; QUANTITATIVE ANALYSIS; SURVIVAL RATE;

ADOLESCENT; ADULT; BONE MARROW; CHILD; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA METHYLATION; FEMALE; HUMANS; INFANT; KARYOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84875825778     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000347038     Document Type: Article

References (20)

1. Vidal DO, Paixão VA, Brait M, Souto EX, Caballero OL, Lopes LF, Vettore AL: Aberrant methylation in pediatric myelodysplastic syndrome. Leuk Res 2007; 31: 175-181
2. Rodrigues EF, SantosVrebouças CB, Gonçal-es Pimentel MM, Mencalha AL, Dobbin J, Da Costa ES, Fernandez Cde S, Bouzas LF, Abdelhay E, De Souza Fernandez T: Epigenetic alterations of p15 (INK4B) and p16 (INK4A) genes in pediatric primary myelodysplastic syndrome. Leuk Lymphoma 2010; 51: 1887-1894
3. Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G, Head DR: A pediatric approach to the WHO classification of myelodysplastic and myeloproliferati-e diseases. Leukemia 2003; 17: 277-282
4. Niemeyer CM, Kratz CP, Hasle H: Pediatric myelodysplastic syndromes. Curr Treat Options Oncol 2005; 6: 209-214
5. Hasegawa D, Manabe A, Kubota T, Kawasaki H, Hirose I, Ohtsuka Y, Tsuruta T, Ebihara Y, Goto Y, Zhao XY, Sakashita K, Koike K, Isomura M, Kojima S, Hoshika A, Tsuji K, Nakahata T: Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and ju-enile myelomonocytic leukaemia. Br J Haematol 2005; 128: 805-812
6. Mandel K, Dror Y, Poon A, Freedman MH: A practical, comprehensi-e classification for pediatric myelodysplastic syndromes: The CCC system. J Pediatr Hematol Oncol 2002; 24: 596-605
7. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues, ed 4. Lion, IARC press, 2008
8. Wong IH, Ng MH, Huang DP, Lee JC: Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: Potential prognostic implications. Blood 2000; 95: 1942-1949
9. Kim M, Oh B, Kim SY, Park HK, Hwang SM, Kim TY, She CJ, Yang I, Yoon SS, Yoon JH, Lee DS: P15INK4b methylation correlates with thrombocytopenia, blast percentage, and sur-i-al in myelodysplastic syndromes in a dose dependent manner: Quantitation using pyrosequencing study. Leuk Res 2010; 34: 718-722
10. Wong IH: Methylation profiling of human cancers in blood: Molecular monitoring and prognostication (review). Int J Oncol 2001; 19: 1319-1324
11. Uchida T, Kinoshita T, Nagai H, Nakahara Y, Saito H, Hotta T, Murate T: Hypermethylation of the p15INK4b gene in myelodysplastic syndromes. Blood 1997; 90: 1403-1409
12. Quesnel B, Guillerm G, Vereecque R, Wattel E, Preudhomme C, Bauters F, Vanrumbeke M, Fenaux P: Methylation of the p15 (INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood 1998; 91: 2985-2990
13. Tien HF, Tang JH, Tsay W, Liu MC, Lee FY, Wang CH, Chen YC, Shen MC: Methylation of the p15 (INK4B) gene in myelodysplastic syndrome: It can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. Br J Haematol 2001; 112: 148-154
14. Hsieh CL: Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol 1994; 14: 5487-5494
15. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB: Methylation-specific PCR: A no-el PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826
16. Hasle H: Myelodysplastic and myeloproliferati-e disorders in children. Curr Opin Pediatr 2007; 19: 1-8
17. Jones PA, Gonzalgo ML: Altered DNA methylation and genome instability: A new pathway to cancer? Proc Natl Acad Sci USA 1997; 94: 2103-2105
18. Lengauer C, Kinzler KW, Vogelstein B: DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci USA 1997; 94: 2545-2550
19. Habano W, Sugai T, Jiao YF, Nakamura S: No-el approach for detecting global epigenetic alterations associated with tumor cell aneuploidy. Int J Cancer 2007; 121: 1487-1493
20. Boks MP, Derks EM, Weisenberger DJ, Strengman E, Janson E, Sommer IE, Kahn RS, Ophoff RA: The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS One 2009; 4:e6767